Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

UKONS 2017 | Managing the care of patients receiving oral systemic anti-cancer therapy (SACT)

Michael Mawhinney • 10 Nov 2017
UKONS 2017
General

The official recommendations are that patients taking oral systemic anti-cancer therapy (SACT) receive the same level as care as those receiving intravenous SACT in a hospital setting. However, this poses many logistical challenges. In this interview, Michael Mawhinney of Oxford Brookes University, Oxford, UK, discusses his review of this issue, which was presented at the UK Oncology Nursing Society (UKONS) Annual Conference 2017 in Harrogate, UK.

More from Michael Mawhinney

4:07
Improving the patient experience of oral SACT
Michael Mawhinney • 16 Nov 2018
0:46
The importance of research in cancer nursing
Michael Mawhinney • 10 Nov 2017
0:46
Patient education and the role of the nurse
Michael Mawhinney • 10 Nov 2017
0:31
Increasing role of the pharmacist in patient care
Michael Mawhinney • 10 Nov 2017

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals